甘李药业：公司将持续关注市场动态

Group 1 - The company, Ganli Pharmaceutical, is monitoring market dynamics and will consider its development stage, strategic needs, and market environment when making decisions regarding potential H-share issuance [1] - If the company decides to proceed with an H-share issuance plan that meets disclosure standards, it will fulfill its disclosure obligations strictly [1]